Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2004

01-10-2004 | Case Report

Successful Unrelated Cord Blood Transplantation Using a Reduced-Intensity Conditioning Regimen in a 6-Month-Old Infant with Congenital Neutropenia Complicated by Severe Pneumonia

Authors: Yozo Nakazawa, Kazuo Sakashita, Mizuho Kinoshita, Ken Saida, Tomonari Shigemura, Ryu Yanagisawa, Takehiko Kamijo, Naoto Shikama, Kenichi Koike

Published in: International Journal of Hematology | Issue 3/2004

Login to get access
Metadata
Title
Successful Unrelated Cord Blood Transplantation Using a Reduced-Intensity Conditioning Regimen in a 6-Month-Old Infant with Congenital Neutropenia Complicated by Severe Pneumonia
Authors
Yozo Nakazawa
Kazuo Sakashita
Mizuho Kinoshita
Ken Saida
Tomonari Shigemura
Ryu Yanagisawa
Takehiko Kamijo
Naoto Shikama
Kenichi Koike
Publication date
01-10-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04079

Other articles of this Issue 3/2004

International Journal of Hematology 3/2004 Go to the issue

OriginalPaper

Cytokine-Mediated Cell Survival

OriginalPaper

Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/ Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells

OriginalPaper

Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin’s Lymphomas: Results of a Japanese Phase II Study

OriginalPaper

Apoptosis of Multiple Myeloma

Case Report

Humanized Anti-Interleukin 6 Receptor Antibody Induced Long-term Remission in a Patient with Life-Threatening Refractory Autoimmune Hemolytic Anemia

Letter to the Editor

Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits